| Literature DB >> 33659279 |
Crystal C Kennedy1, Erin E Brown2, Nadia O Abutaleb2, George A Truskey2.
Abstract
The vascular endothelium is present in all organs and blood vessels, facilitates the exchange of nutrients and waste throughout different organ systems in the body, and sets the tone for healthy vessel function. Mechanosensitive in nature, the endothelium responds to the magnitude and temporal waveform of shear stress in the vessels. Endothelial dysfunction can lead to atherosclerosis and other diseases. Modeling endothelial function and dysfunction in organ systems in vitro, such as the blood-brain barrier and tissue-engineered blood vessels, requires sourcing endothelial cells (ECs) for these biomedical engineering applications. It can be difficult to source primary, easily renewable ECs that possess the function or dysfunction in question. In contrast, human pluripotent stem cells (hPSCs) can be sourced from donors of interest and renewed almost indefinitely. In this review, we highlight how knowledge of vascular EC development in vivo is used to differentiate induced pluripotent stem cells (iPSC) into ECs. We then describe how iPSC-derived ECs are being used currently in in vitro models of organ function and disease and in vivo applications.Entities:
Keywords: cell differentiation; induced pluripotent stem cells; organoids; vascular endothelium; vascular tissue engineering
Year: 2021 PMID: 33659279 PMCID: PMC7917070 DOI: 10.3389/fcvm.2021.625016
Source DB: PubMed Journal: Front Cardiovasc Med ISSN: 2297-055X